Studies Currently Enrolling Patients

We have several clinical research studies that are currently enrolling patients, if you are interested in participating please contact Caroline Price at 312-695-0513

 

Chronic Rhinosinusitis (CRS) Registry

The purpose of this registry is to collect clinical information on all consenting chronic rhinosinusitis (CRS) patients seen at the Sinus and Allergy Center. With this information, we will conduct studies to learn more about CRS and determine the most effective ways to treat this disease. The registry will also allow us to identify possible subjects for future studies. We will review the electronic medical records of consenting patients for CRS-relevant medical care and will enter this information into a secure computerized database. Participating in this study may help us better understand CRS, which may lead to improved care and treatment. Consenting patients will complete a 10 minute questionnaire at specific time points. There are additional, optional components such as smell testing and research-related CT scans that will be done at no cost if the patient agrees to these components. If you are interested in participating in this study, please ask your doctor during your clinic appointment.

RESOLVE II – Steroid-Releasing S8 Sinus Implant

This is the follow up study to the RESOLVE I- S8 Steroid- Releasing Implant Trial. The goal of this study is to assess the safety and efficacy of the steroid-releasing S8 Sinus Implant in individuals who have previously had functional endoscopic sinus surgery in the past but still experienced nasal and sinus obstruction. The S8 Sinus Implant creates and maintains an opening in the sinus and is intended to provide a physical opening in order to restore ventilation and drainage as well as decrease the feeling of nasal obstruction or congestion. Enrolled subjects who meet eligibility criteria were randomly assigned (like flipping a coin) to one of two groups: a treatment group who received the implant and a control group who did not receive the implant. This study is sponsored by Intersect ENT.

Aspirin Exacerbated Respiratory Disease (AERD) Study

The purpose of this study is to evaluate the cause of Aspirin Exacerbated Respiratory Disease (AERD) also known as Samter’s Disease. Taking part in this study and participating in the experimental tests required by this study (questionnaires, nasal inspiratory flow, spirometry, nasal endoscopy, nasal culture, smell test, collection of blood, collection of exhaled breath condensate, collection of induced sputum, collection of nasal secretions by lavage or sponges, collection of nasal brushings, collection of saliva, collection of urine, collection and preservation of tissue, and testing of collected tissue )may also help scientists to better understand why people develop AERD, why people with AERD have reactions to medications like aspirin, and why treating AERD patients with high doses of aspirin improve their condition.

 

AZD1981 in CRSwNP

This is a Phase IIa, single-center, randomized, placebo controlled, double-blind study to assess the efficacy of AZD1981, a CRTH2 antagonist drug, in patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). This is a 5 month study that includes 3 phases: screening period, a 12 week treatment period (randomized to AZD1981 or placebo), and a washout period. Patients taking part in this study and the study procedures (sinus CTs, spirometry tests, nasal endoscopies, etc.) may experience decreased polyp size and nasal symptoms associated with nasal polyps, however it is not known if benefits are maintained after treatment.